ProKidney Historical Balance Sheet

PROK Stock

USD 0.96 0.02 2.13%

Trend analysis of ProKidney Corp balance sheet accounts such as Net Tangible Assets of 609.7 M, Property Plant And Equipment Net of 24 M, Accounts Payable of 2.9 M or Cash of 126.6 M provides information on ProKidney Corp's total assets, liabilities, and equity, which is the actual value of ProKidney Corp to its prevalent stockholders. By breaking down trends over time using ProKidney Corp balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining ProKidney Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether ProKidney Corp is a good buy for the upcoming year.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProKidney Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.

About ProKidney Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of ProKidney Corp at a specified time, usually calculated after every quarter, six months, or one year. ProKidney Corp Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of ProKidney Corp and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which ProKidney currently owns. An asset can also be divided into two categories, current and non-current.

ProKidney Corp Balance Sheet Chart

At this time, ProKidney Corp's Other Stockholder Equity is quite stable compared to the past year. Total Liabilities is expected to rise to about 41.4 M this year, although the value of Total Stockholder Equity is projected to rise to (945.2 M).

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Total Assets

Total assets refers to the total amount of ProKidney Corp assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in ProKidney Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on ProKidney Corp balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of ProKidney Corp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from ProKidney Corp's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into ProKidney Corp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProKidney Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.At this time, ProKidney Corp's Other Stockholder Equity is quite stable compared to the past year. Total Liabilities is expected to rise to about 41.4 M this year, although the value of Total Stockholder Equity is projected to rise to (945.2 M).

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	2.4M	4.4M	2.5M	2.4M
Total Assets	518.0M	420.6M	441.1M	267.0M

Short Long Term Debt Total Total Assets

ProKidney Corp balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Capital Lease Obligations	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		0.85	0.7	0.75	-0.98	0.94	0.81	-0.75	-0.96	0.87	0.76	0.81	0.54	1.0	-0.13	0.88	0.74	0.76	1.0	-0.61	-0.85	0.71	-0.85	0.85	-0.97	0.72
Short Long Term Debt Total	0.85		0.68	0.75	-0.89	0.84	0.9	-0.4	-0.87	0.93	0.42	0.9	0.36	0.83	-0.05	0.97	0.59	0.77	0.83	-0.66	-0.74	0.71	-0.77	0.97	-0.88	0.83
Other Current Liab	0.7	0.68		0.99	-0.79	0.88	0.84	-0.23	-0.85	0.76	0.26	0.84	0.87	0.66	0.19	0.77	0.97	0.99	0.68	-0.63	-0.67	0.71	-0.82	0.75	-0.81	0.84
Total Current Liabilities	0.75	0.75	0.99		-0.84	0.91	0.88	-0.27	-0.89	0.83	0.3	0.88	0.83	0.71	0.17	0.82	0.95	1.0	0.73	-0.67	-0.69	0.75	-0.86	0.8	-0.85	0.87
Total Stockholder Equity	-0.98	-0.89	-0.79	-0.84		-0.98	-0.84	0.67	0.99	-0.88	-0.69	-0.84	-0.58	-0.97	0.15	-0.91	-0.81	-0.85	-0.97	0.62	0.9	-0.7	0.86	-0.9	1.0	-0.77
Net Tangible Assets	0.94	0.84	0.88	0.91	-0.98		0.84	-0.61	-1.0	0.86	0.63	0.84	0.69	0.93	-0.09	0.88	0.9	0.91	0.93	-0.62	-0.89	0.71	-0.87	0.87	-0.99	0.79
Property Plant And Equipment Net	0.81	0.9	0.84	0.88	-0.84	0.84		-0.23	-0.86	0.91	0.25	1.0	0.67	0.77	0.14	0.96	0.75	0.89	0.78	-0.67	-0.68	0.76	-0.83	0.93	-0.83	0.97
Net Debt	-0.75	-0.4	-0.23	-0.27	0.67	-0.61	-0.23		0.63	-0.46	-1.0	-0.23	-0.13	-0.79	0.21	-0.37	-0.41	-0.28	-0.78	0.39	0.58	-0.44	0.55	-0.33	0.66	-0.08
Retained Earnings	-0.96	-0.87	-0.85	-0.89	0.99	-1.0	-0.86	0.63		-0.89	-0.65	-0.86	-0.65	-0.95	0.08	-0.91	-0.87	-0.9	-0.95	0.65	0.88	-0.74	0.89	-0.89	1.0	-0.8
Accounts Payable	0.87	0.93	0.76	0.83	-0.88	0.86	0.91	-0.46	-0.89		0.47	0.91	0.47	0.85	0.13	0.92	0.71	0.84	0.85	-0.77	-0.62	0.85	-0.94	0.88	-0.88	0.83
Cash	0.76	0.42	0.26	0.3	-0.69	0.63	0.25	-1.0	-0.65	0.47		0.24	0.15	0.8	-0.21	0.38	0.44	0.31	0.79	-0.41	-0.6	0.46	-0.56	0.34	-0.68	0.1
Non Current Assets Total	0.81	0.9	0.84	0.88	-0.84	0.84	1.0	-0.23	-0.86	0.91	0.24		0.67	0.76	0.14	0.96	0.74	0.89	0.77	-0.67	-0.68	0.76	-0.82	0.93	-0.83	0.98
Non Currrent Assets Other	0.54	0.36	0.87	0.83	-0.58	0.69	0.67	-0.13	-0.65	0.47	0.15	0.67		0.49	0.2	0.54	0.89	0.81	0.52	-0.4	-0.56	0.5	-0.6	0.5	-0.59	0.72
Cash And Short Term Investments	1.0	0.83	0.66	0.71	-0.97	0.93	0.77	-0.79	-0.95	0.85	0.8	0.76	0.49		-0.17	0.85	0.71	0.73	1.0	-0.59	-0.85	0.68	-0.83	0.82	-0.96	0.67
Common Stock Shares Outstanding	-0.13	-0.05	0.19	0.17	0.15	-0.09	0.14	0.21	0.08	0.13	-0.21	0.14	0.2	-0.17		-0.06	0.14	0.16	-0.15	-0.65	0.45	0.58	-0.23	-0.17	0.15	0.05
Non Current Liabilities Total	0.88	0.97	0.77	0.82	-0.91	0.88	0.96	-0.37	-0.91	0.92	0.38	0.96	0.54	0.85	-0.06		0.69	0.84	0.86	-0.61	-0.8	0.69	-0.79	0.99	-0.9	0.92
Other Current Assets	0.74	0.59	0.97	0.95	-0.81	0.9	0.75	-0.41	-0.87	0.71	0.44	0.74	0.89	0.71	0.14	0.69		0.95	0.73	-0.61	-0.71	0.7	-0.82	0.66	-0.83	0.73
Total Liab	0.76	0.77	0.99	1.0	-0.85	0.91	0.89	-0.28	-0.9	0.84	0.31	0.89	0.81	0.73	0.16	0.84	0.95		0.74	-0.67	-0.71	0.75	-0.86	0.82	-0.86	0.88
Total Current Assets	1.0	0.83	0.68	0.73	-0.97	0.93	0.78	-0.78	-0.95	0.85	0.79	0.77	0.52	1.0	-0.15	0.86	0.73	0.74		-0.6	-0.85	0.69	-0.84	0.82	-0.96	0.68
Intangible Assets	-0.61	-0.66	-0.63	-0.67	0.62	-0.62	-0.67	0.39	0.65	-0.77	-0.41	-0.67	-0.4	-0.59	-0.65	-0.61	-0.61	-0.67	-0.6		0.27	-0.98	0.8	-0.52	0.62	-0.52
Common Stock	-0.85	-0.74	-0.67	-0.69	0.9	-0.89	-0.68	0.58	0.88	-0.62	-0.6	-0.68	-0.56	-0.85	0.45	-0.8	-0.71	-0.71	-0.85	0.27		-0.36	0.56	-0.82	0.9	-0.68
Property Plant Equipment	0.71	0.71	0.71	0.75	-0.7	0.71	0.76	-0.44	-0.74	0.85	0.46	0.76	0.5	0.68	0.58	0.69	0.7	0.75	0.69	-0.98	-0.36		-0.89	0.6	-0.7	0.61
Good Will	-0.85	-0.77	-0.82	-0.86	0.86	-0.87	-0.83	0.55	0.89	-0.94	-0.56	-0.82	-0.6	-0.83	-0.23	-0.79	-0.82	-0.86	-0.84	0.8	0.56	-0.89		-0.74	0.86	-0.73
Capital Lease Obligations	0.85	0.97	0.75	0.8	-0.9	0.87	0.93	-0.33	-0.89	0.88	0.34	0.93	0.5	0.82	-0.17	0.99	0.66	0.82	0.82	-0.52	-0.82	0.6	-0.74		-0.89	0.91
Net Invested Capital	-0.97	-0.88	-0.81	-0.85	1.0	-0.99	-0.83	0.66	1.0	-0.88	-0.68	-0.83	-0.59	-0.96	0.15	-0.9	-0.83	-0.86	-0.96	0.62	0.9	-0.7	0.86	-0.89		-0.76
Property Plant And Equipment Gross	0.72	0.83	0.84	0.87	-0.77	0.79	0.97	-0.08	-0.8	0.83	0.1	0.98	0.72	0.67	0.05	0.92	0.73	0.88	0.68	-0.52	-0.68	0.61	-0.73	0.91	-0.76

Click cells to compare fundamentals

ProKidney Corp Account Relationship Matchups

ProKidney Corp balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	16.7M	40.3M	518.0M	420.6M	441.1M	267.0M
Short Long Term Debt Total	1.6M	1.3M	2.4M	4.4M	2.5M	2.4M
Other Current Liab	4.5M	9.2M	7.1M	17.7M	31.9M	33.5M
Total Current Liabilities	5.5M	12.3M	10.9M	25.0M	36.2M	38.0M
Total Stockholder Equity	9.9M	26.9M	(1.1B)	(1.1B)	(995.0M)	(945.2M)
Property Plant And Equipment Net	10.5M	12.6M	13.1M	46.4M	45.2M	24.0M
Net Debt	(3.0M)	(19.2M)	(487.9M)	(56.2M)	(96.6M)	(101.5M)
Retained Earnings	(106.4M)	(161.5M)	(1.1B)	(1.1B)	(1.2B)	(1.1B)
Accounts Payable	781K	2.8M	3.0M	5.1M	3.6M	2.9M
Cash	4.6M	20.6M	490.3M	60.6M	99.1M	126.6M
Non Current Assets Total	11.1M	13.0M	13.3M	46.4M	45.2M	24.4M
Cash And Short Term Investments	4.6M	20.6M	490.3M	363.0M	358.3M	229.5M
Liabilities And Stockholders Equity	16.7M	40.3M	518.0M	420.6M	441.1M	267.0M
Non Current Liabilities Total	1.3M	1.1M	2.2M	4.2M	3.2M	2.4M
Other Current Assets	1.0M	6.7M	14.5M	9.8M	35.1M	36.9M
Total Liab	6.8M	13.4M	13.1M	29.2M	39.4M	41.4M
Total Current Assets	5.6M	27.3M	504.7M	374.1M	395.9M	242.6M
Common Stock	116.2M	188.4M	24K	23K	29K	27.6K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether ProKidney Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ProKidney Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Prokidney Corp Stock. Highlighted below are key reports to facilitate an investment decision about Prokidney Corp Stock:

How To Invest In ProKidney

Details

Is ProKidney Stock a good investment?

Details

What is ProKidney Corp's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.

You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.62)

Revenue Per Share

0.001

Return On Assets

(0.26)

Return On Equity

(0.41)

The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ProKidney Historical Balance Sheet

About ProKidney Balance Sheet Analysis

ProKidney Corp Balance Sheet Chart

Total Assets

Total Current Liabilities

ProKidney Corp balance sheet Correlations

ProKidney Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

ProKidney Corp balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Net Invested Capital	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Net Invested Capital	+ 1.0	Retained Earnings

Cash	- 1.0	Net Debt
Retained Earnings	- 1.0	Net Tangible Assets
Net Invested Capital	- 0.99	Net Tangible Assets
Property Plant Equipment	- 0.98	Intangible Assets
Net Tangible Assets	- 0.98	Total Stockholder Equity
Total Stockholder Equity	- 0.98	Total Assets